Advertisement
Screener

EMERGENT BIOSOLUTIONS INC. (EBS) Increase (Decrease) in Employee Related Liabilities

2.8 / 5 stars · 68/120 Roast Me

EMERGENT BIOSOLUTIONS INC. Increase (Decrease) in Employee Related Liabilities

EMERGENT BIOSOLUTIONS INC. (EBS) reported Increase (Decrease) in Employee Related Liabilities of -$16.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-06

  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $4.20M, a 28.81% decline year-over-year.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$20.20M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $4.50M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $4.50M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2025 was -$17.30M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2024 was -$18.20M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2023 was -$10.40M.
  • EMERGENT BIOSOLUTIONS INC. increase (decrease) in employee related liabilities for fiscal 2022 was -$800.00K, a 120.00% decline from fiscal 2021.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 3 month as first filedIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 6 month as first filedIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 9 month as first filedIncrease (Decrease) in Employee Related Liabilities 12 monthIncrease (Decrease) in Employee Related Liabilities 12 month as first filed
2026-06-30$4.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$16.00M
10-Q · filed 2026-08-06
-$11.50M
derived: sum of 3 quarters · filed 2026-08-06
-$7.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$20.20M
10-Q · filed 2026-05-01
-$15.70M
derived: sum of 2 quarters · filed 2026-05-01
-$11.20M
derived: sum of 3 quarters · filed 2026-05-01
-$5.30M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$9.00M
derived: sum of 2 quarters · filed 2026-02-27
$14.90M
derived: sum of 3 quarters · filed 2026-08-06
-$17.30M
10-K · filed 2026-02-27
2025-09-30$4.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$10.40M
derived: sum of 2 quarters · filed 2026-08-06
-$21.80M
10-Q · filed 2025-10-30
-$30.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$5.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$26.30M
10-Q · filed 2026-08-06
-$34.60M
derived: sum of 3 quarters · filed 2026-08-06
-$37.50M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$32.20M
10-Q · filed 2026-05-01
-$40.50M
derived: sum of 2 quarters · filed 2026-05-01
-$43.40M
derived: sum of 3 quarters · filed 2026-05-01
-$17.10M
derived: sum of 4 quarters · filed 2026-05-01
2024-12-31-$8.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$11.20M
derived: sum of 2 quarters · filed 2026-02-27
$15.10M
derived: sum of 3 quarters · filed 2026-02-27
-$18.20M
10-K · filed 2026-02-27
2024-09-30-$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$23.40M
derived: sum of 2 quarters · filed 2025-10-30
-$9.90M
10-Q · filed 2025-10-30
-$19.50M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$26.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
-$7.00M
10-Q · filed 2025-08-07
-$16.60M
derived: sum of 3 quarters · filed 2026-02-27
-$5.00M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$33.30M
10-Q · filed 2025-05-08
-$42.90M
derived: sum of 2 quarters · filed 2026-02-27
-$31.30M
derived: sum of 3 quarters · filed 2026-02-27
-$19.40M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$9.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$2.00M
derived: sum of 2 quarters · filed 2026-02-27
$13.90M
derived: sum of 3 quarters · filed 2026-02-27
-$10.40M
10-K · filed 2026-02-27
2023-09-30$11.60M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$23.50M
derived: sum of 2 quarters · filed 2024-11-07
-$800.00K
10-Q · filed 2024-11-07
$4.10M
derived: sum of 4 quarters · filed 2025-03-04
2023-06-30$11.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$12.40M
10-Q · filed 2024-08-07
-$13.40M
10-Q · filed 2023-08-09
-$7.50M
derived: sum of 3 quarters · filed 2025-03-04
$900.00K
derived: sum of 4 quarters · filed 2025-03-04
2023-03-31-$24.30M
10-Q · filed 2024-05-02
-$25.30M
10-Q · filed 2023-05-10
-$19.40M
derived: sum of 2 quarters · filed 2025-03-04
-$11.00M
derived: sum of 3 quarters · filed 2025-03-04
$7.10M
derived: sum of 4 quarters · filed 2025-03-04
2022-12-31$4.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04
$13.30M
derived: sum of 2 quarters · filed 2025-03-04
$31.40M
derived: sum of 3 quarters · filed 2025-03-04
-$800.00K
10-K · filed 2025-03-04
$100.00K
10-K · filed 2023-03-01
2022-09-30$8.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-11
$26.50M
derived: sum of 2 quarters · filed 2023-12-11
-$5.70M
10-Q · filed 2023-12-11
$9.40M
derived: sum of 4 quarters · filed 2024-03-08
2022-06-30$18.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
-$14.10M
10-Q · filed 2023-08-09
$1.00M
derived: sum of 3 quarters · filed 2024-03-08
$11.30M
derived: sum of 4 quarters · filed 2024-03-08
2022-03-31-$32.20M
10-Q · filed 2023-05-10
-$17.10M
derived: sum of 2 quarters · filed 2024-03-08
-$6.80M
derived: sum of 3 quarters · filed 2024-03-08
$1.20M
derived: sum of 4 quarters · filed 2024-03-08
2021-12-31$15.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08
$25.40M
derived: sum of 2 quarters · filed 2024-03-08
$33.40M
derived: sum of 3 quarters · filed 2024-03-08
$4.00M
10-K · filed 2024-03-08
2021-09-30$10.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$18.30M
derived: sum of 2 quarters · filed 2022-11-09
-$11.10M
10-Q · filed 2022-11-09
-$3.80M
derived: sum of 4 quarters · filed 2023-12-11
2021-06-30$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
-$21.40M
10-Q · filed 2022-08-02
-$14.10M
derived: sum of 3 quarters · filed 2023-12-11
$3.80M
derived: sum of 4 quarters · filed 2023-12-11
2021-03-31-$29.40M
10-Q · filed 2022-04-29
-$22.10M
derived: sum of 2 quarters · filed 2023-12-11
-$4.20M
derived: sum of 3 quarters · filed 2023-12-11
$7.30M
derived: sum of 4 quarters · filed 2023-12-11
2020-12-31$7.30M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11
$25.20M
derived: sum of 2 quarters · filed 2023-12-11
$36.70M
derived: sum of 3 quarters · filed 2023-12-11
$21.80M
10-K/A · filed 2023-12-11
2020-09-30$17.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$29.40M
derived: sum of 2 quarters · filed 2021-11-05
$14.50M
10-Q · filed 2021-11-05
$21.10M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$11.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30
-$3.40M
10-Q · filed 2021-07-30
$3.20M
derived: sum of 3 quarters · filed 2022-02-25
$14.30M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$14.90M
10-Q · filed 2021-04-30
-$8.30M
derived: sum of 2 quarters · filed 2022-02-25
$2.80M
derived: sum of 3 quarters · filed 2022-02-25
$10.60M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$6.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$17.70M
derived: sum of 2 quarters · filed 2022-02-25
$25.50M
derived: sum of 3 quarters · filed 2022-02-25
$4.20M
10-K · filed 2022-02-25
2019-09-30$11.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
$18.90M
derived: sum of 2 quarters · filed 2020-11-06
-$2.40M
10-Q · filed 2020-11-06
$2.10M
derived: sum of 4 quarters · filed 2021-02-19
2019-06-30$7.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
-$13.50M
10-Q · filed 2020-07-31
-$9.00M
derived: sum of 3 quarters · filed 2021-02-19
$3.50M
derived: sum of 4 quarters · filed 2021-02-19
2019-03-31-$21.30M
10-Q · filed 2020-05-01
-$16.80M
derived: sum of 2 quarters · filed 2021-02-19
-$4.30M
derived: sum of 3 quarters · filed 2021-02-19
$500.00K
derived: sum of 4 quarters · filed 2021-02-19
2018-12-31$4.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19
$17.00M
derived: sum of 2 quarters · filed 2021-02-19
$21.80M
derived: sum of 3 quarters · filed 2021-02-19
$8.40M
10-K · filed 2021-02-19
2018-09-30$12.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$17.30M
derived: sum of 2 quarters · filed 2019-11-07
$3.90M
10-Q · filed 2019-11-07
$3.92M
10-Q · filed 2018-11-02
$9.10M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$4.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
-$8.60M
10-Q · filed 2019-08-02
-$8.62M
10-Q · filed 2018-08-03
-$3.40M
derived: sum of 3 quarters · filed 2020-02-25
$4.89M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31-$13.40M
10-Q · filed 2019-05-08
-$13.37M
10-Q · filed 2018-05-04
-$8.20M
derived: sum of 2 quarters · filed 2020-02-25
$94.00K
derived: sum of 3 quarters · filed 2020-02-25
$1.10M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$5.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$13.49M
derived: sum of 2 quarters · filed 2020-02-25
$14.50M
derived: sum of 3 quarters · filed 2020-02-25
$3.30M
10-K · filed 2020-02-25
$3.35M
10-K · filed 2018-02-23
2017-09-30$8.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02
$9.30M
derived: sum of 2 quarters · filed 2018-11-02
-$1.90M
10-Q · filed 2018-11-02
$450.00K
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$10.19M
10-Q · filed 2018-08-03
-$7.84M
derived: sum of 3 quarters · filed 2019-02-22
-$3.03M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31-$11.20M
10-Q · filed 2018-05-04
-$8.85M
derived: sum of 2 quarters · filed 2019-02-22
-$4.04M
derived: sum of 3 quarters · filed 2019-02-22
-$726.00K
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$2.35M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$7.17M
derived: sum of 2 quarters · filed 2019-02-22
$10.48M
derived: sum of 3 quarters · filed 2019-02-22
$2.20M
10-K · filed 2019-02-22
$2.24M
10-K · filed 2017-02-28
2016-09-30$4.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03
$8.13M
derived: sum of 2 quarters · filed 2017-11-03
-$152.00K
10-Q · filed 2017-11-03
$4.22M
derived: sum of 4 quarters · filed 2018-02-23
2016-06-30$3.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04
-$4.97M
10-Q · filed 2017-08-04
-$598.00K
derived: sum of 3 quarters · filed 2018-02-23
$3.19M
derived: sum of 4 quarters · filed 2018-02-23
2016-03-31-$8.28M
10-Q · filed 2017-05-05
-$3.91M
derived: sum of 2 quarters · filed 2018-02-23
-$124.00K
derived: sum of 3 quarters · filed 2018-02-23
$5.29M
derived: sum of 4 quarters · filed 2018-02-23
2015-12-31$4.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23
$8.15M
derived: sum of 2 quarters · filed 2018-02-23
$13.56M
derived: sum of 3 quarters · filed 2018-02-23
$2.68M
10-K · filed 2018-02-23
2015-09-30$3.79M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09
$9.20M
derived: sum of 2 quarters · filed 2016-11-09
-$1.69M
10-Q · filed 2016-11-09
$3.06M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$5.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$5.47M
10-Q · filed 2016-08-05
-$726.00K
derived: sum of 3 quarters · filed 2017-02-28
$2.97M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$10.88M
10-Q · filed 2016-05-06
-$6.14M
derived: sum of 2 quarters · filed 2017-02-28
-$2.44M
derived: sum of 3 quarters · filed 2017-02-28
$2.38M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$4.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
$8.44M
derived: sum of 2 quarters · filed 2017-02-28
$13.26M
derived: sum of 3 quarters · filed 2017-02-28
$4.54M
10-K · filed 2017-02-28
2014-09-30$3.69M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06
$8.51M
derived: sum of 2 quarters · filed 2015-11-06
-$208.00K
10-Q · filed 2015-11-06
$6.05M
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$4.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
-$3.90M
10-Q · filed 2015-08-06
$2.35M
derived: sum of 3 quarters · filed 2016-02-29
$5.32M
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31-$8.72M
10-Q · filed 2015-05-08
-$2.46M
derived: sum of 2 quarters · filed 2016-02-29
$502.00K
derived: sum of 3 quarters · filed 2016-02-29
$4.35M
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$6.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$9.22M
derived: sum of 2 quarters · filed 2016-02-29
$13.07M
derived: sum of 3 quarters · filed 2016-02-29
$2.09M
10-K · filed 2016-02-29
2013-09-30$2.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$6.82M
derived: sum of 2 quarters · filed 2014-11-10
-$4.16M
10-Q · filed 2014-11-10
$2.27M
derived: sum of 4 quarters · filed 2015-03-09
2013-06-30$3.85M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08
-$7.13M
10-Q · filed 2014-08-08
-$691.00K
derived: sum of 3 quarters · filed 2015-03-09
$1.42M
derived: sum of 4 quarters · filed 2015-03-09
2013-03-31-$10.98M
10-Q · filed 2014-05-12
-$4.54M
derived: sum of 2 quarters · filed 2015-03-09
-$2.43M
derived: sum of 3 quarters · filed 2015-03-09
$1.56M
derived: sum of 4 quarters · filed 2015-03-09
2012-12-31$6.44M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09
$8.55M
derived: sum of 2 quarters · filed 2015-03-09
$12.54M
derived: sum of 3 quarters · filed 2015-03-09
$1.65M
10-K · filed 2015-03-09
2012-09-30$2.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08
$6.11M
derived: sum of 2 quarters · filed 2013-11-08
-$4.79M
10-Q · filed 2013-11-08
$1.26M
derived: sum of 4 quarters · filed 2014-03-10
2012-06-30$4.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
-$6.90M
10-Q · filed 2013-08-06
-$853.00K
derived: sum of 3 quarters · filed 2014-03-10
-$43.00K
derived: sum of 4 quarters · filed 2014-03-10
2012-03-31-$10.89M
10-Q · filed 2013-05-03
-$4.85M
derived: sum of 2 quarters · filed 2014-03-10
-$4.04M
derived: sum of 3 quarters · filed 2014-03-10
-$3.67M
derived: sum of 4 quarters · filed 2014-03-10
2011-12-31$6.05M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10
$6.86M
derived: sum of 2 quarters · filed 2014-03-10
$7.22M
derived: sum of 3 quarters · filed 2014-03-10
-$3.30M
10-K · filed 2014-03-10
2011-09-30$810.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01
$1.18M
derived: sum of 2 quarters · filed 2012-11-01
-$9.35M
10-Q · filed 2012-11-01
-$9.24M
10-Q · filed 2011-11-04
-$2.82M
derived: sum of 4 quarters · filed 2013-03-08
2011-06-30$365.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03
-$10.16M
10-Q · filed 2012-08-03
-$10.15M
10-Q · filed 2011-08-05
-$3.63M
derived: sum of 3 quarters · filed 2013-03-08
-$639.00K
derived: sum of 4 quarters · filed 2013-03-08
2011-03-31-$10.53M
10-Q · filed 2012-05-04
-$3.99M
derived: sum of 2 quarters · filed 2013-03-08
-$1.00M
derived: sum of 3 quarters · filed 2013-03-08
2010-12-31$6.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08
$9.52M
derived: sum of 2 quarters · filed 2013-03-08
$6.17M
10-K · filed 2013-03-08
2010-09-30$2.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04
-$356.00K
10-Q · filed 2011-11-04
2010-06-30-$3.35M
10-Q · filed 2011-08-05
2009-12-31$3.40M
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Larimar Therapeutics, Inc. (LRMR)United States$0.344B-1.83
Vogenx, Inc. (VOGX)United States$0.355B
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Rezolute, Inc. (RZLT)United States$0.382B-6.45